ALBERTDAVD
vs
B
BSE Sensex 30
ALBERTDAVD
Over the past 12 months, ALBERTDAVD has underperformed BSE Sensex 30, delivering a return of -14% compared to the BSE Sensex 30's +1% growth.
Stocks Performance
ALBERTDAVD vs BSE Sensex 30
Performance Gap
ALBERTDAVD vs BSE Sensex 30
Performance By Year
ALBERTDAVD vs BSE Sensex 30
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Albert David Ltd
Glance View
Albert David Ltd. engages in the manufacture and trade of pharmaceuticals. The company is headquartered in Kolkata, West Bengal and currently employs 1,326 full-time employees. The company went IPO on 2016-06-14. The firm offers its products under various categories, which includes parenterals, oral/enteral, topical agents and vision care. Its parenterals consists of amino acids infusion, antimicrobial, anti-leishmaniasis (kalazar), hemostat, neurotropic vitamin and placenta extract. Its oral/enteral consists of amino acids oral, anthelmintic, anti-microbial, anti ulcerants, anti-vertigo, appetite stimulants, anti-tubercular, haematinics, oral vitamin b complex and expectorant / cough syrup. Its topical agents consist of non-steroidal anti-inflammatory drugs (NSAID). Its vision care consists of anti-glaucoma, anti-infective, tear substitutes and anti-infective with NSAID. The firm's plants are located at Gupta Lane, Kolkata and Meerut Road, Industrial Area, Ghaziabad.
